PARTNERS CAPITAL INVESTMENT GROUP, LLP

Position in URGN — UroGen Pharma Ltd.

CIK 1694870 Boston, MA

Position in URGN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$566,131

+$289,527 QoQ

Shares Held

15,384

0.0% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#97

of 190 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PARTNERS CAPITAL INVESTMENT GROUP, LLP holds $5,273,927 across 5 Biotechnology names. URGN ranks #4 (10.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	13,963	$1,582,845
2	ARGX	Argenx SE	1,656	$1,536,387
3	ONC	BeOne Medicines Ltd.	4,395	$1,252,443
4	URGN	UroGen Pharma Ltd. This page	15,384	$566,131
5	ALLO	Allogene Therapeutics, Inc.	161,597	$336,121

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$566,131	15,384	0.0%	Shares	Sole	2026-08-13
2026-03-31	$276,604	15,384	0.0%	Shares	Sole	2026-05-12
2025-12-31	$360,293	15,384	0.0%	Shares	Sole	2026-02-13
2025-09-30	$306,910	15,384	0.0%	Shares	Sole	2025-10-31
2025-06-30	$210,760	15,384	0.0%	Shares	Sole	2025-08-14
2025-03-31	$170,147	15,384	0.0%	Shares	Sole	2025-05-14
2024-09-30	$195,376	15,384	0.0%	Shares	Sole	2024-11-05
2024-06-30	$258,143	15,384	0.0%	Shares	Sole	2024-08-13
2023-12-31	$230,760	15,384	0.0%	Shares	Sole	2024-02-12
2023-09-30	$215,529	15,384	0.0%	Shares	Sole	2023-11-14
2023-06-30	$159,224	15,384	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.